B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS
Abstract
Disclosed is a newly identified B7 family member, zB7H6, which functions as a counter-receptor for the NK cell triggering receptor, NKp30. Methods and compositions for modulating NKp30-mediated NK cell activity based on the interaction of zB7H6 with NKp30, as well as related screening methods, are also disclosed. Further disclosed are anti-zB7H6 antibodies as well as antibody-drug conjugates comprising an anti-zB7H6 antibody conjugated to a therapeutic agent, including methods for using such antibodies and antibody-drug conjugates to exert therapeutic effects against zB7H6-expressing cells.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated antibody that specifically binds to the extracellular domain of zB7H6, wherein the extracellular domain of zB7H6 is residues 25-266 of SEQ ID NO: 2, and further wherein said antibody comprises an Fc region having at least one of ADCC activity and CDC activity.
2 . The antibody of claim 1 , which is a monoclonal antibody.
3 . The antibody of claim 2 , which is a human monoclonal antibody or a humanized monoclonal antibody.
4 . The antibody of claim 2 , which is a single chain antibody.
5 . An antibody of claim 2 , wherein the Fc region is a single chain Fc (scFc).
6 . A pharmaceutical composition comprising an antibody of claim 1 and a pharmaceutically acceptable carrier.
7 . A pharmaceutical composition comprising an antibody of claim 2 and a pharmaceutically acceptable carrier.
8 . A pharmaceutical composition comprising an antibody of claim 3 and a pharmaceutically acceptable carrier.
9 . A pharmaceutical composition comprising an antibody of claim 4 and a pharmaceutically acceptable carrier.
10 . A pharmaceutical composition comprising an antibody of claim 5 and a pharmaceutically acceptable carrier.Join the waitlist — get patent alerts
Track US2018258172A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.